Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose IL-2 in Liver Transplant Recipients
NCT02739412Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Nov 2016
- Primary completion
- Jul 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in liver transplantation, sponsored by Beth Israel Deaconess Medical Center. Started Nov 2016; status: completed.
02
Drugs
aldesleukin
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT02739412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739412.